Back to Search
Start Over
Chronic Obstructive Pulmonary Disease Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron
- Source :
- M2 Presswire. December 14, 2023
- Publication Year :
- 2023
-
Abstract
- M2 PRESSWIRE-December 14, 2023-: Chronic Obstructive Pulmonary Disease Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron (C)1994-2023 M2 [...]
- Subjects :
- Genentech Inc. -- Forecasts and trends
Regeneron Pharmaceuticals Inc. -- Forecasts and trends
AstraZeneca PLC -- Forecasts and trends
Sanofi S.A. -- Forecasts and trends
Biological products industry -- Forecasts and trends
BCG vaccines -- Forecasts and trends
BCG -- Forecasts and trends
Biotechnology industry -- Forecasts and trends
Lung diseases, Obstructive -- Forecasts and trends
Drug approval -- Forecasts and trends
Epidemiology -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Market trend/market analysis
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.776300352